A natural glycoprotein inhibitor (NIF) of CD11b/CD18 reduces leukocyte adhesion in the liver after hemorrhagic shock

Shock

Volumn 4, Issue 3, 1995, Pages 187-192

  Soule, Howard R ^b   Moyle, Matthew ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b Dendreon   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; GLYCOPROTEIN; HELMINTH PROTEIN; MEMBRANE PROTEIN; NIF PROTEIN, ANCYLOSTOMA CANINUM;

ANIMAL; ARTICLE; CELL ADHESION; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; HEMODYNAMICS; HEMORRHAGIC SHOCK; LEUKOCYTE; LIVER; LIVER CIRCULATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; ANTIGENS, CD18; CELL ADHESION; FEMALE; GLYCOPROTEINS; HELMINTH PROTEINS; HEMODYNAMIC PROCESSES; LEUKOCYTES; LIVER; LIVER CIRCULATION; MACROPHAGE-1 ANTIGEN; MEMBRANE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, HEMORRHAGIC;

EID: 0029366577     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/00024382-199509000-00006     Document Type: Article

References (33)

1. Simpson R, Alon R, Valeri CR, Shepro D, Hechtman HB: Integrindependent neutrophil adhesion following gut ischemia and reperfusion. Behring Inst Mitt 92:210-217, 1993.
2. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992.
3. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 84:2068-2101, 1994.
4. Schleimer RP, Rutledge BK: Cultured human vascular endothelial cells acquire adhesiveness of neutrophils after stimulation with interleukin-1, endotoxin, and tumor-promoting phorbol diesters. J Immunol 136:649-654, 1986.
5. Nishida J, McDonnell D, Krasovich MA, Ekataksin W, McCuskey RS: Effects of interleukin-1α on hepatic phagocytic cells and sinusodal microcirculation. In Knook DL, Wisse E (ed): Cells of the Hepatic Sinusoid. Leiden, The Netherlands: The Kupffer Cell Foundation, 1993, pp 148-151.
6. Furie MB, McHugh DD: Migration of neutrophils across endothelial monolayers is stimulated by treatment of the monolayers with interleukin-1 or tumor necrosis factor-α. J Immunol 143:3309-3317, 1989.
7. Bevilacqua MP, Pober JS, Wheeler ME, Mendrick D, Cotran RS, Gimbrone MA: Interleukin-1 acts on cultured human vascular endothelial cells to increase the adhesion of polymorphonuclear leukocytes, monocytes and related leukocyte cell lines. J Clin Invest 76:2003-2012, 1985.
8. von Andrian UH, Chambers JD, McEvoy LM, Bargatze RF, Arfors K-E, Butcher EC: Two-step model of leukocyte-endothelial cell interaction in inflammation: Distinct roles for LECAM-1 and the leukocyte β2 integrins in vivo. Proc Natl Acad Sci USA 88:7538-7542, 1991.
9. Jutila MA: Leukocyte traffic to sites of inflammation. Acta Pathol Microbiol Immunol Scand 100:191-201, 1992.
10. Stacker SA, Springer TA: Leukocyte integrin P150,95 (CD11c/CD18) functions as an adhesion molecule binding to a counter-receptor on stimulated endothelium. J Immunol 146:648-655, 1991.
11. Fan ST, Edgington TS: Integrin regulation of leukocyte inflammatory functions. J Immunol 150:2972-2980, 1993.
12. Mileski WJ, Winn RK, Vedder NB, Pohlman TH, Harlan JM, Rice CL: Inhibition of CD18-dependent neutrophil adherence reduces organ injury after hemorrhagic shock in primates. Surgery 108:206-212, 1990.
13. Moyle M, Foster DL, McGrath DE, et al: A hookworm glycoprotein that inhibits neutrophil function is a ligand of the integrin CDllb/CD18. J Biol Chem 268:10008-10016, 1994.
14. Muchowski PJ, Zhang L, Chang ER, Soule HR, Plow EF, Moyle M: Functional interaction between the integrin antagonist neutrophil inhibitory factor and the I domain of CD11b/CD18. J Biol Chem 269:26419-26423, 1994.
15. Marzi I, Bauer C, Hower R, Bühren V: Leukocyte-endothelial cell interactions in the liver after hemorrhagic shock in the rat. Circ Shock 40:105-114, 1993.
16. Ferguson D, McDonagh PF, Biewer J, Paidas CN, Clemens MG: Spatial relationship between leukocyte accumulation and microvascular injury during reperfusion following hepatic ischemia. Int J Microcirc Clin Exp 12:45-60, 1993.
17. Bauer C, Marzi I, Bauer M, Fellger H, Larsen R: Interleukin-1 receptor antagonist attenuates leukocyte-endothelial interactions in the liver following hemorrhagic shock in the rat. Crit Care Med 23:1099-1105, 1995.
18. Marzi I, Bauer M, Secchi A, Bahrami S, Redl H, Schlag G: Effect of anti-TNFα on leukocyte adhesion in the liver after hemorrhagic shock: An intravital microscopic study in the rat. Shock 3:27-33, 1995.
19. Marzi I: Bedeutung der Leber für den Verlauf des SIRS nach Schock, Trauma und bei Sepsis. Anästhesiol Intensivmed Notfallmed Schmerzther 29:41-46, 1994.
20. Fukuoka T, Nakajima Y, Matsumoto M, Segawa M, Kanehiro H, Hisanaga M, Wada T, Nakano H: Effect of platelet-activating factor antagonist (CV6209) on shock caused by temporary hepatic inflow occlusion. Life Sci 47:565-570, 1990.
21. Marzi I, Walcher F, Bühren V: Macrophage activation and leukocyte adhesion after liver transplantation. Am J Physiol 265:G172-G177, 1993.
22. Rappaport AM: Acinar units and the pathophysiology of the liver. In Rouiller C (ed): The Liver. Morphology, Biochemistry, Physiology. Vol. I. London: Academic Press, 1963, pp 265-328.
23. Fujita H, Morita I, Murota S: A possible mechanism for vascular endothelial cell injury elicited by activated leukocytes: A significant involvement of adhesion molecules, CD11/CD18, and ICAM-1. Arch Biochem Biophys 309:62-69, 1994.
24. Winn RK, Vedder NB, Mihelcic D, Flaherty LC, Langdale L, Harlan JM: The role of adhesion molecules in reperfusion injury. Agents Actions 41:113-126, 1993.
25. Siegel JH: The liver as modulator of the host-defense response: Hostdefense failure as a manifestation of hepatic decompensation. In Schlag G, Redl H, Siegel JH (ed): Shock, Sepsis, and Organ Failure. Second Wiggers-Bernard-Conference. Berlin, Heidelberg: Springer Verlag, 1992, pp 149-206.
26. Redl H, Gasser H, Schlag G, Marzi I: Involvement of oxygen radicals in shock-related cell injury. Br Med Bull 49:556-565, 1993.
27. Goldman G, Welbourn R, Klausner JM, Valeri CR, Shepro D, Hechtman HB: Oxygen free radicals are required for ischemia-induced leukotriene B4 synthesis and diapedesis. Surgery 111:287-293, 1992.
28. Szabó C, Wu C-C, Gross SS, Thiemermann C, Vane JR: Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo. Eur J Pharmacol 250:157-160, 1993.
29. Wright CD, Mülsch A, Busse R, Osswald H: Generation of nitric oxide by human neutrophils. Biochem Biophys Res Commun 160:813-819, 1989.
30. Ley K: Leukocyte rolling: Transient adhesion mediated by vascular selectins. Eur J Physiol Suppl:R8, 1993.
31. Luscinskas FW, Cybulsky MI, Kiely J-M, Peckins CS, Davis VM, Gimbrone MA Jr: Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. J Immunol 146:1617-1625, 1991.
32. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ, Smith CW: Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver. Hepatology 17:915-923, 1993.
33. Langdale LA, Flaherty LC, Liggitt HD, Harlan JM, Rice CL, Winn RK: Neutrophils contribute to hepatic ischemia-reperfusion injury by a CD18-independent mechanism. J. Leukocyte Biol 53:511-517, 1993.